ArticleDrug design, development and therapy2022

Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects.

Ling Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.